Variant report

Variant	nsv3783
Chromosome Location	chr3:42926223-42970597
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:238)
CpG islands
(count:1223)
Chromatin interactive
region (count:12)
LncRNA
region (count:8)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:238 , 50 per page) page: 1 2 3 4 5

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr3:42933842-42933850	K562	blood:	n/a	n/a
2	ARID3A	chr3:42955943-42956619	HepG2	liver:	n/a	n/a
3	ATF1	chr3:42943695-42944162	K562	blood:	n/a	n/a
4	ATF2	chr3:42932502-42932863	H1-hESC	embryonic stem cell:	n/a	n/a
5	ATF2	chr3:42932513-42932900	H1-hESC	embryonic stem cell:	n/a	n/a
6	BACH1	chr3:42940533-42940597	K562	blood:	n/a	n/a
7	BCL11A	chr3:42932601-42932799	H1-hESC	embryonic stem cell:	n/a	n/a
8	CBX3	chr3:42956400-42956769	K562	blood:	n/a	n/a
9	CBX3	chr3:42956308-42956744	K562	blood:	n/a	n/a
10	CCNT2	chr3:42943732-42944103	K562	blood:	n/a	n/a
11	CCNT2	chr3:42947583-42947712	K562	blood:	n/a	n/a
12	CEBPB	chr3:42956279-42956538	HepG2	liver:	n/a	n/a
13	CEBPB	chr3:42956270-42956595	IMR90	lung:	n/a	n/a
14	CEBPB	chr3:42942106-42942598	MCF-7	breast:	n/a	n/a
15	CEBPB	chr3:42956232-42956668	ECC-1	luminal epithelium:	n/a	n/a
16	CEBPB	chr3:42956229-42956601	Hela-S3	cervix:	n/a	n/a
17	CEBPB	chr3:42956193-42956633	H1-hESC	embryonic stem cell:	n/a	n/a
18	CEBPB	chr3:42956196-42956576	HepG2	liver:	n/a	n/a
19	CEBPB	chr3:42956253-42956629	HepG2	liver:	n/a	n/a
20	CEBPB	chr3:42956358-42956596	K562	blood:	n/a	n/a
21	CEBPB	chr3:42932685-42932839	H1-hESC	embryonic stem cell:	n/a	n/a
22	CEBPB	chr3:42942106-42942617	MCF-7	breast:	n/a	n/a
23	CEBPB	chr3:42956149-42956633	HepG2	liver:	n/a	n/a
24	CEBPB	chr3:42956298-42956528	ECC-1	luminal epithelium:	n/a	n/a
25	CHD2	chr3:42932632-42932997	H1-hESC	embryonic stem cell:	n/a	n/a
26	CTCF	chr3:42940860-42941010	GM12869	blood:	n/a	n/a
27	CTCF	chr3:42947580-42947730	SK-N-SH_RA	brain:	n/a	n/a
28	CTCF	chr3:42940715-42941156	K562	blood:	n/a	n/a
29	CTCF	chr3:42940880-42941030	AG09309	skin:	n/a	n/a
30	CTCF	chr3:42940970-42941019	GM19239	blood:	n/a	n/a
31	CTCF	chr3:42940900-42941050	GM12865	blood:	n/a	n/a
32	CTCF	chr3:42940880-42941030	GM12875	blood:	n/a	n/a
33	CTCF	chr3:42940920-42941070	K562	blood:	n/a	n/a
34	CTCF	chr3:42947798-42947889	Fibrobl	skin:	n/a	n/a
35	CTCF	chr3:42940940-42941090	RPTEC	kidney:	n/a	n/a
36	CTCF	chr3:42940940-42941090	GM12864	blood:	n/a	n/a
37	CTCF	chr3:42940934-42940970	GM13977	blood:	n/a	n/a
38	CTCF	chr3:42940780-42940930	HA-sp	spinal cord:	n/a	n/a
39	CTCF	chr3:42940900-42941050	HMEC	breast:	n/a	n/a
40	CTCF	chr3:42940900-42941050	GM12878	blood:	n/a	n/a
41	CTCF	chr3:42940928-42941031	GM12878	blood:	n/a	n/a
42	CTCF	chr3:42940982-42940996	GM19240	blood:	n/a	n/a
43	CTCF	chr3:42940860-42941010	GM06990	blood:	n/a	n/a
44	CTCF	chr3:42940900-42941050	HCT-116	colon:	n/a	n/a
45	CTCF	chr3:42947560-42947710	HCPEpiC	choroid plexus:	n/a	n/a
46	CTCF	chr3:42952719-42952750	Lung_OC	lung:	n/a	n/a
47	CTCF	chr3:42940937-42940995	H1-hESC	embryonic stem cell:	n/a	n/a
48	CTCF	chr3:42940820-42940970	HPAF	blood vessel:	n/a	n/a
49	CTCF	chr3:42940860-42941010	NHDF-neo	bronchial:	n/a	n/a
50	CTCF	chr3:42947440-42947590	AG09309	skin:	n/a	n/a

(count:1223 , 50 per page) page: 1 2 3 4 5 6 7 ... 25

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr3:42950090-42950140	H1-hESC	embryonic stem cell:	embryo
2	chr3:42944225-42944275	ECC-1	luminal epithelium:	n/a
3	chr3:42947990-42948040	SK-N-SH	brain:	n/a
4	chr3:42950090-42950140	H1-hESC	embryonic stem cell:	embryo
5	chr3:42944225-42944275	ECC-1	luminal epithelium:	n/a
6	chr3:42947990-42948040	SK-N-SH	brain:	n/a
7	chr3:42947385-42947435	NH-A	brain:	n/a
8	chr3:42960358-42960408	BE2_C	brain:	n/a
9	chr3:42944225-42944275	HEK293	kidney:	embryo
10	chr3:42958846-42958896	HCM	heart:	n/a
11	chr3:42959937-42959987	SAEC	small airway:	n/a
12	chr3:42949540-42949590	AG04449	skin:	fetal
13	chr3:42960358-42960408	HEEpiC	esophagus:	n/a
14	chr3:42947267-42947317	AG09319	gingival:	n/a
15	chr3:42947690-42947740	HRCEpiC	kidney:	n/a
16	chr3:42951263-42951313	HepG2	liver:	n/a
17	chr3:42947481-42947531	K562	blood:	n/a
18	chr3:42944225-42944275	BJ	skin:	n/a
19	chr3:42951263-42951313	IMR90	lung:	fetal
20	chr3:42958846-42958896	ECC-1	luminal epithelium:	n/a
21	chr3:42960358-42960408	NH-A	brain:	n/a
22	chr3:42951263-42951313	BE2_C	brain:	n/a
23	chr3:42951263-42951313	HCF	heart:	n/a
24	chr3:42950090-42950140	HUVEC	blood vessel:	n/a
25	chr3:42947263-42947313	Hela-S3	cervix:	n/a
26	chr3:42947565-42947615	IMR90	lung:	fetal
27	chr3:42944225-42944275	NB4	blood:	n/a
28	chr3:42946536-42946586	GM12878	blood:	n/a
29	chr3:42951380-42951430	HepG2	liver:	n/a
30	chr3:42947267-42947317	HIPEpiC	eye:	n/a
31	chr3:42947990-42948040	Hepatocyte	liver:	n/a
32	chr3:42946536-42946586	Hepatocyte	liver:	n/a
33	chr3:42947690-42947740	LNCaP	prostate:	n/a
34	chr3:42960358-42960408	Caco-2	colon:	n/a
35	chr3:42947263-42947313	HAEpiC	amniotic membrane:	n/a
36	chr3:42947267-42947317	GM12878	blood:	n/a
37	chr3:42949540-42949590	NHDF-neo	bronchial:	n/a
38	chr3:42951380-42951430	NB4	blood:	n/a
39	chr3:42950090-42950140	HCT-116	colon:	n/a
40	chr3:42944225-42944275	MCF-7	breast:	n/a
41	chr3:42948169-42948219	Hela-S3	cervix:	n/a
42	chr3:42947481-42947531	GM12878	blood:	n/a
43	chr3:42960358-42960408	NB4	blood:	n/a
44	chr3:42947990-42948040	HCF	heart:	n/a
45	chr3:42947481-42947531	ovcar-3	ovarian:	n/a
46	chr3:42947565-42947615	HPAEpiC	pulmonary alveolar:	n/a
47	chr3:42946536-42946586	NH-A	brain:	n/a
48	chr3:42947690-42947740	GM06990	blood:	n/a
49	chr3:42947385-42947435	NHBE	bronchial:	n/a
50	chr3:42950090-42950140	PrEC	prostate:	n/a

(count:12 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr3:42935964..42938886-chr3:42940569..42942633,2	MCF-7	breast:
2	chr3:42936127..42937782-chr3:42940399..42942185,2	K562	blood:
3	chr3:42844539..42847348-chr3:42939373..42941976,2	MCF-7	breast:
4	chr3:42896746..42897559-chr3:42942281..42943111,2	MCF-7	breast:
5	chr3:42936127..42937782-chr3:42940399..42942185,2	K562	blood:
6	chr3:42943767..42945323-chr3:42982157..42984728,2	MCF-7	breast:
7	chr3:42930456..42931958-chr3:42943223..42945031,2	MCF-7	breast:
8	chr3:42946486..42948443-chr3:42951858..42953439,2	K562	blood:
9	chr3:42935964..42938886-chr3:42940569..42942633,2	MCF-7	breast:
10	chr3:42925984..42928803-chr3:42932233..42934720,2	K562	blood:
11	chr3:42941210..42943818-chr3:42945759..42947502,2	MCF-7	breast:
12	chr3:42925984..42928803-chr3:42932233..42934720,2	K562	blood:

(count:8 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CCBP2-2	chr3:42950294-42950401	NONHSAT089272
2	lnc-CCBP2-2	chr3:42954693-42954795	NONHSAT089272
3	lnc-KRBOX1-1	chr3:42938530-42938816	ENSG00000273328.1
4	lnc-KRBOX1-1	chr3:42949514-42949597	ENSG00000273328.1
5	lnc-CCBP2-2	chr3:42953509-42953561	NONHSAT089272
6	lnc-KRBOX1-1	chr3:42938530-42941828	ENSG00000273328.1
7	lnc-KRBOX1-1	chr3:42929030-42929193	ENSG00000273328.1
8	lnc-KRBOX1-1	chr3:42929030-42929193	ENSG00000273328.1

No data

Variant related genes	Relation type
HNRNPA1P22	TF binding region
ZNF662	TF binding region
HNRNPA1P22	CpG island
ZNF662	CpG island
ENSG00000182983	chromatin interactions
ENSG00000144648	chromatin interactions
ENSG00000181061	chromatin interactions
ENSG00000236459	chromatin interactions
ENSG00000240747	chromatin interactions

Extended variants
information (count: 1383 )
Associated
traits (count: 92 )

Variant overlapped rSNPs/rCNVs (count:1383 , 50 per page) page: 1 2 3 4 5 6 7 ... 28

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs115765895	chr3:42926267-42926268	Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs553309535	chr3:42926353-42926354	Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs573457020	chr3:42926385-42926386	Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs371727460	chr3:42926390-42926391	Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs567195033	chr3:42926399-42926400	Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs546098737	chr3:42926490-42926491	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs545383375	chr3:42926526-42926527	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs565244556	chr3:42926537-42926538	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs530919770	chr3:42926567-42926568	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs139434086	chr3:42926593-42926594	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs150058643	chr3:42926644-42926645	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs530251970	chr3:42926674-42926675	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs182826352	chr3:42926711-42926712	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs17074867	chr3:42926730-42926731	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs532387916	chr3:42926732-42926733	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs144896639	chr3:42926749-42926750	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs142827728	chr3:42926811-42926812	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs149020734	chr3:42926866-42926867	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs537442207	chr3:42926916-42926917	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs188262212	chr3:42926947-42926948	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs376234742	chr3:42926957-42926958	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs567784858	chr3:42926989-42926990	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs533675425	chr3:42927003-42927004	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs72499008	chr3:42927050-42927051	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs145893139	chr3:42927175-42927176	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs376322183	chr3:42927179-42927180	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs545626138	chr3:42927213-42927214	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs558985239	chr3:42927228-42927229	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs199748501	chr3:42927269-42927270	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs149309771	chr3:42927273-42927274	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs559912230	chr3:42927291-42927292	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs561283191	chr3:42927356-42927357	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs147788479	chr3:42927396-42927397	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs369845900	chr3:42927397-42927398	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs1427802	chr3:42927399-42927400	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
36	rs141211517	chr3:42927495-42927496	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs566482163	chr3:42927551-42927552	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs552393467	chr3:42927566-42927567	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs562417526	chr3:42927593-42927594	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs114791580	chr3:42927665-42927666	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs185109245	chr3:42927685-42927686	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs374780715	chr3:42927699-42927700	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs368832724	chr3:42927710-42927711	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs112346472	chr3:42927720-42927721	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs533847077	chr3:42927732-42927733	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs1346415	chr3:42927740-42927741	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs201482651	chr3:42927756-42927757	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs570573962	chr3:42927769-42927770	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs538836499	chr3:42927785-42927786	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs559229179	chr3:42927869-42927870	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:92)

Disease	PMID	Source
Glioblastoma multiforme	21080181	CNVD
Neuroblastoma	18923191	CNVD
Colorectal cancer	21297112	CNVD
Lynch syndrome	18415027	CNVD
Renal cell carcinoma	18592004	CNVD
Acute myeloid leukemia	20729466	CNVD
Urothelial carcinoma	18382360	CNVD
Melanoma	18172304	CNVD
Cervical cancer	21062161	CNVD
Hirschsprung''s Disease	21712996	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Insulin resistance	16721378	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Ewing''s sarcoma	21437220	CNVD
Neuroblastoma	21484798	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Oral cancer	19627613	CNVD
Renal cell carcinoma	19461508	CNVD
Epithelial cancer	22065749	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Acute myeloid leukemia	16864856	CNVD
Liposarcoma	21253554	CNVD
Basal cell lymphoma	21115979	CNVD
Endometrial cancer	22040021	CNVD
Pancreatic endocrine tumor	20981439	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	17387387	CNVD
Oral cancer	21386901	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Retinoblastoma	21504564	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Renal cell carcinoma	21668985	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	17603634	CNVD
Esophageal cancer	20955586	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Breast cancer	17133270	CNVD
Uveal melanoma	20484589	CNVD
Autism	22495311	CNVD
Melanoma	20688739	CNVD
Acute myeloid leukemia	21251322	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cancer	21183584	CNVD
Wilms tumour	17204608	CNVD
Biliary cancer	19435499	CNVD
Non-small cell lung cancer	20864512	CNVD
Non-small cell lung cancer	21829676	CNVD
Kartagener syndrome	16639409	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Bipolar disorder	20877625	CNVD
Bipolar disorder	21956041	CNVD
Bipolar disorder	22241247	CNVD
Biliary cancer	18923514	CNVD
Breast cancer	21509527	CNVD
Melanoma	21693616	CNVD
Myelofibrosis	22110671	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Breast cancer	20409316	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Breast cancer	21364760	CNVD
abnormal development	18461090	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Prostate cancer	18632612	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Ovarian cancer	21781307	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:851 , 50 per page) page: 1 2 3 4 5 6 7 ... 18

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:42923000-42927200	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
2	chr3:42923000-42928000	Weak transcription	Placenta Amnion	Placenta Amnion
3	chr3:42923200-42928000	Weak transcription	Duodenum Mucosa	Duodenum
4	chr3:42923200-42928000	Weak transcription	Stomach Mucosa	stomach
5	chr3:42923200-42928200	Weak transcription	iPS-18 Cell Line	embryonic stem cell
6	chr3:42923200-42928600	Weak transcription	Fetal Intestine Small	intestine
7	chr3:42923400-42927800	Weak transcription	iPS-20b Cell Line	embryonic stem cell
8	chr3:42923600-42927400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
9	chr3:42924000-42935800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
10	chr3:42925800-42926600	Enhancers	HUES6 Cell Line	embryonic stem cell
11	chr3:42925800-42926600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
12	chr3:42925800-42927600	Enhancers	Breast Myoepithelial Primary Cells	Breast
13	chr3:42925800-42928200	Weak transcription	Placenta	Placenta
14	chr3:42926000-42926400	Enhancers	ES-I3 Cell Line	embryonic stem cell
15	chr3:42926000-42926400	Enhancers	H1 Cell Line	embryonic stem cell
16	chr3:42926000-42926400	Enhancers	HUES48 Cell Line	embryonic stem cell
17	chr3:42926000-42926600	Enhancers	HUES64 Cell Line	embryonic stem cell
18	chr3:42926000-42926600	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
19	chr3:42926000-42926600	Enhancers	HMEC	breast
20	chr3:42926200-42926400	Enhancers	ES-WA7 Cell Line	embryonic stem cell
21	chr3:42926200-42926600	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
22	chr3:42926200-42927800	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
23	chr3:42926400-42927400	Weak transcription	ES-I3 Cell Line	embryonic stem cell
24	chr3:42926400-42931800	Weak transcription	HUES48 Cell Line	embryonic stem cell
25	chr3:42926400-42933000	Weak transcription	H1 Cell Line	embryonic stem cell
26	chr3:42926600-42927200	Flanking Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
27	chr3:42926600-42927400	Weak transcription	HUES6 Cell Line	embryonic stem cell
28	chr3:42926600-42927400	Weak transcription	HUES64 Cell Line	embryonic stem cell
29	chr3:42926600-42927600	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
30	chr3:42926600-42927800	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
31	chr3:42926600-42928000	Weak transcription	HMEC	breast
32	chr3:42927200-42927600	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
33	chr3:42927200-42929400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
34	chr3:42927400-42928200	Enhancers	HUES64 Cell Line	embryonic stem cell
35	chr3:42927400-42928200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
36	chr3:42927400-42928600	Enhancers	HUES6 Cell Line	embryonic stem cell
37	chr3:42927400-42929000	Enhancers	ES-I3 Cell Line	embryonic stem cell
38	chr3:42927600-42928400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
39	chr3:42927600-42933200	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
40	chr3:42927800-42928000	Enhancers	Fetal Kidney	kidney
41	chr3:42927800-42928200	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
42	chr3:42927800-42928200	Enhancers	iPS-20b Cell Line	embryonic stem cell
43	chr3:42927800-42928600	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
44	chr3:42928000-42928200	Enhancers	Placenta Amnion	Placenta Amnion
45	chr3:42928000-42928200	Enhancers	HMEC	breast
46	chr3:42928000-42929400	Enhancers	Duodenum Mucosa	Duodenum
47	chr3:42928000-42930200	Enhancers	Stomach Mucosa	stomach
48	chr3:42928200-42928600	Enhancers	iPS-18 Cell Line	embryonic stem cell
49	chr3:42928200-42928800	Weak transcription	HUES64 Cell Line	embryonic stem cell
50	chr3:42928200-42929400	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links